{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T03:21:32Z","timestamp":1787541692548,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04249-0","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:52:30Z","timestamp":1773413550000},"page":"3754-3773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The early diagnostic value of lung cancer autoantibodies and tumor markers in lung cancer"],"prefix":"10.1007","volume":"28","author":[{"given":"Yanyan","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0217-4437","authenticated-orcid":false,"given":"Pengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiande","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"2","key":"4249_CR1","first-page":"87","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"4249_CR2","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1056\/NEJMoa060476","volume":"355","author":"CI Henschke","year":"2006","unstructured":"Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355(17):1763\u201371.","journal-title":"N Engl J Med"},{"issue":"1","key":"4249_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12890-019-0883-x","volume":"19","author":"KL Huang","year":"2019","unstructured":"Huang KL, Wang SY, Lu WC, Chang YH, Su J, Lu YT. Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis. BMC Pulm Med. 2019;19(1):126.","journal-title":"BMC Pulm Med"},{"issue":"3","key":"4249_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/cancers14030623","volume":"14","author":"L Benning","year":"2022","unstructured":"Benning L, Peintner A, Peintner L. Advances in and the applicability of machine learning-based screening and early detection approaches for cancer: a primer. Cancers (Basel). 2022;14(3):623.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4249_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40364-023-00486-5","volume":"11","author":"S Hu","year":"2023","unstructured":"Hu S, Tao J, Peng M, Ye Z, Chen Z, Chen H, et al. Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers. Biomark Res. 2023;11(1):45.","journal-title":"Biomark Res"},{"issue":"11","key":"4249_CR6","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/clinchem\/48.11.1931","volume":"48","author":"J Kulpa","year":"2002","unstructured":"Kulpa J, W\u00f3jcik E, Reinfuss M, Ko\u0142odziejski L. Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21\u20131, and neuron-specific enolase in squamous cell lung cancer patients. Clin Chem. 2002;48(11):1931\u20137.","journal-title":"Clin Chem"},{"issue":"4","key":"4249_CR7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/labmed\/lmac122","volume":"54","author":"H Bi","year":"2022","unstructured":"Bi H, Yin L, Fang W, Song S, Wu S, Shen J. Association of CEA, NSE, CYFRA 21\u20131, SCC-Ag, and ProGRP with clinicopathological characteristics and chemotherapeutic outcomes of lung cancer. Lab Med. 2022;54(4):372\u20139.","journal-title":"Lab Med"},{"issue":"1","key":"4249_CR8","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1186\/s12885-022-09728-5","volume":"22","author":"J Yuan","year":"2022","unstructured":"Yuan J, Sun Y, Wang K, Wang Z, Li D, Fan M, et al. Development and validation of reassigned CEA, CYFRA21-1 and NSE-based models for lung cancer diagnosis and prognosis prediction. BMC Cancer. 2022;22(1):686.","journal-title":"BMC Cancer"},{"issue":"3","key":"4249_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/bios8030067","volume":"8","author":"J Qiu","year":"2018","unstructured":"Qiu J, Keyser B, Lin ZT, Wu T. Autoantibodies as potential biomarkers in breast cancer. Biosensors (Basel). 2018;8(3):67.","journal-title":"Biosensors (Basel)"},{"key":"4249_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.970623","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Guo X, Jin B, Zhu Q. Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization. Front Oncol. 2022;12:970623.","journal-title":"Front Oncol"},{"issue":"1","key":"4249_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12935-023-03107-1","volume":"23","author":"T Li","year":"2023","unstructured":"Li T, Xia J, Yun H, Sun G, Shen Y, Wang P, et al. A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma. Cancer Cell Int. 2023;23(1):273.","journal-title":"Cancer Cell Int"},{"issue":"16","key":"4249_CR12","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.3390\/cancers15164064","volume":"15","author":"C Qiu","year":"2023","unstructured":"Qiu C, Wang X, Batson SA, Wang B, Casiano CA, Francia G, et al. A Luminex approach to develop an anti-tumor-associated antigen autoantibody panel for the detection of prostate cancer in racially\/ethnically diverse populations. Cancers (Basel). 2023;15(16):4064.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"4249_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182117","volume":"12","author":"ZM Tang","year":"2017","unstructured":"Tang ZM, Ling ZG, Wang CM, Wu YB, Kong JL. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: a systematic review and meta-analysis. PLoS ONE. 2017;12(7):e0182117.","journal-title":"PLoS ONE"},{"key":"4249_CR14","doi-asserted-by":"publisher","first-page":"1035402","DOI":"10.3389\/fimmu.2022.1035402","volume":"13","author":"R Yang","year":"2022","unstructured":"Yang R, Han Y, Yi W, Long Q. Autoantibodies as biomarkers for breast cancer diagnosis and prognosis. Front Immunol. 2022;13:1035402.","journal-title":"Front Immunol"},{"key":"4249_CR15","doi-asserted-by":"publisher","first-page":"1343020","DOI":"10.3389\/fimmu.2024.1343020","volume":"15","author":"S Soussan","year":"2024","unstructured":"Soussan S, Pupier G, Cremer I, Joubert PE, Saut\u00e8s-Fridman C, Fridman WH, et al. Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint monoclonal antibody therapies. Front Immunol. 2024;15:1343020.","journal-title":"Front Immunol"},{"issue":"6","key":"4249_CR16","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1159\/000495935","volume":"51","author":"J Qin","year":"2018","unstructured":"Qin J, Zeng N, Yang T, Wan C, Chen L, Shen Y, et al. Diagnostic value of autoantibodies in lung cancer: a systematic review and meta-analysis. Cell Physiol Biochem. 2018;51(6):2631\u201346.","journal-title":"Cell Physiol Biochem"},{"key":"4249_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658922","volume":"12","author":"D Jiang","year":"2021","unstructured":"Jiang D, Zhang X, Liu M, Wang Y, Wang T, Pei L, et al. Discovering panel of autoantibodies for early detection of lung cancer based on focused protein array. Front Immunol. 2021;12:658922.","journal-title":"Front Immunol"},{"issue":"4","key":"4249_CR18","first-page":"922","volume":"64","author":"M Yin-Yu","year":"2018","unstructured":"Yin-Yu M, Fu-Yi X, Fei-Bo W, Ri-Yi Z, Xiao-Lin Y. Performance evaluation of an enzyme-linked immunosorbent assay for seven autoantibodies in lung cancer. Clin Lab. 2018;64(4):922\u201330.","journal-title":"Clin Lab"},{"issue":"9","key":"4249_CR19","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.jtho.2019.06.011","volume":"14","author":"H Balata","year":"2019","unstructured":"Balata H, Fong KM, Hendriks LE, Lam S, Ostroff JS, Peled N, et al. Prevention and early detection for NSCLC: advances in thoracic oncology 2018. J Thorac Oncol. 2019;14(9):1513\u201327.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"4249_CR20","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1111\/crj.12769","volume":"12","author":"Q Du","year":"2018","unstructured":"Du Q, Yu R, Wang H, Yan D, Yuan Q, Ma Y, et al. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer. Clin Respir J. 2018;12(6):2020\u20138.","journal-title":"Clin Respir J"},{"issue":"2","key":"4249_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1384108","volume":"7","author":"S Ren","year":"2018","unstructured":"Ren S, Zhang S, Jiang T, He Y, Ma Z, Cai H, et al. Early detection of lung cancer by using an autoantibody panel in Chinese population. Oncoimmunology. 2018;7(2):e1384108.","journal-title":"Oncoimmunology"},{"issue":"1","key":"4249_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02396-8","volume":"21","author":"HE Marei","year":"2021","unstructured":"Marei HE, Althani A, Afifi N, Hasan A, Caceci T, Pozzoli G, et al. p53 signaling in cancer progression and therapy. Cancer Cell Int. 2021;21(1):703.","journal-title":"Cancer Cell Int"},{"key":"4249_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.903075","volume":"9","author":"M Babamohamadi","year":"2022","unstructured":"Babamohamadi M, Babaei E, Ahmed Salih B, Babamohammadi M, Jalal Azeez H, Othman G. Recent findings on the role of wild-type and mutant p53 in cancer development and therapy. Front Mol Biosci. 2022;9:903075.","journal-title":"Front Mol Biosci"},{"key":"4249_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107889","volume":"98","author":"X Meng","year":"2021","unstructured":"Meng X, Sun X, Liu Z, He Y. A novel era of cancer\/testis antigen in cancer immunotherapy. Int Immunopharmacol. 2021;98:107889.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"4249_CR25","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.21037\/tcr.2019.07.25","volume":"8","author":"S Li","year":"2019","unstructured":"Li S, Ma Y, Xiong Y, Zhang P, Wang X, Wang Y, et al. Five tumor-associated autoantibodies expression levels in serum predict lung cancer and associate with poor outcome. Transl Cancer Res. 2019;8(4):1364\u201373.","journal-title":"Transl Cancer Res"},{"issue":"6","key":"4249_CR26","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.21037\/jtd-21-835","volume":"13","author":"B Luo","year":"2021","unstructured":"Luo B, Mao G, Ma H, Chen S. The role of seven autoantibodies in lung cancer diagnosis. J Thorac Dis. 2021;13(6):3660\u20138.","journal-title":"J Thorac Dis"},{"issue":"22","key":"4249_CR27","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-5357","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, Jiao Y, Ding CM, Sun WZ. The role of autoantibody detection in the diagnosis and staging of lung cancer. Ann Transl Med. 2021;9(22):1673.","journal-title":"Ann Transl Med"},{"key":"4249_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2019.08.007","volume":"67","author":"D Novak","year":"2020","unstructured":"Novak D, H\u00fcser L, Elton JJ, Umansky V, Altevogt P, Utikal J. SOX2 in development and cancer biology. Semin Cancer Biol. 2020;67:74\u201382.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"4249_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2174\/1389203720666190325102255","volume":"20","author":"S Chaudhary","year":"2019","unstructured":"Chaudhary S, Islam Z, Mishra V, Rawat S, Ashraf GM, Kolatkar PR. Sox2: A regulatory factor in tumorigenesis and metastasis. Curr Protein Pept Sci. 2019;20(6):495\u2013504.","journal-title":"Curr Protein Pept Sci"},{"issue":"11","key":"4249_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24020","volume":"35","author":"P Chen","year":"2021","unstructured":"Chen P, Li W, Cheng T. Seven tumor-associated autoantibodies as a serum biomarker for primary screening of early-stage non-small cell lung cancer. J Clin Lab Anal. 2021;35(11):e24020.","journal-title":"J Clin Lab Anal"},{"key":"4249_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.883543","volume":"12","author":"L Xu","year":"2022","unstructured":"Xu L, Chang N, Yang T, Lang Y, Zhang Y, Che Y, et al. Development of diagnosis model for early lung nodules based on a seven autoantibodies panel and imaging features. Front Oncol. 2022;12:883543.","journal-title":"Front Oncol"},{"issue":"1","key":"4249_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06081-9","volume":"9","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Jiang YY, Xie JJ, Mayakonda A, Hazawa M, Chen L, et al. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression. Nat Commun. 2018;9(1):3619.","journal-title":"Nat Commun"},{"key":"4249_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.lungcan.2018.07.003","volume":"123","author":"XD Jiao","year":"2018","unstructured":"Jiao XD, Qin BD, You P, Cai J, Zang YS. The prognostic value of TP53 and its correlation with EGFR mutation in advanced non-small cell lung cancer, an analysis based on cBioPortal data base. Lung Cancer. 2018;123:70\u20135.","journal-title":"Lung Cancer"},{"issue":"6","key":"4249_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/jclinpath-2016-203718","volume":"70","author":"M Sang","year":"2017","unstructured":"Sang M, Gu L, Yin D, Liu F, Lian Y, Zhang X, et al. MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarray. J Clin Pathol. 2017;70(6):533\u201340.","journal-title":"J Clin Pathol"},{"issue":"5676","key":"4249_CR35","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez JG, J\u00e4nne PA, Lee JC, Tracy S, Greulich H, Gabriel S, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004;304(5676):1497\u2013500.","journal-title":"Science"},{"key":"4249_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.953726","volume":"13","author":"H Ma","year":"2022","unstructured":"Ma H, Murphy C, Loscher CE, O\u2019Kennedy R. Autoantibodies - enemies, and\/or potential allies? Front Immunol. 2022;13:953726.","journal-title":"Front Immunol"},{"issue":"2","key":"4249_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020316","volume":"11","author":"S Khorami Sarvestani","year":"2023","unstructured":"Khorami Sarvestani S, Shojaeian S, Sarrami-Forooshani R, Yekaninejad MS, Gilany K, Ghaderi A, et al. Cancer is associated with the emergence of placenta-reactive autoantibodies. Biomedicines. 2023;11(2):316.","journal-title":"Biomedicines"},{"issue":"1","key":"4249_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/s24010037","volume":"24","author":"S Das","year":"2024","unstructured":"Das S, Dey MK, Devireddy R, Gartia MR. Biomarkers in cancer detection, diagnosis, and prognosis. Sensors (Basel). 2024;24(1):37.","journal-title":"Sensors (Basel)"},{"key":"4249_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baac077","volume":"2022","author":"Y Geng","year":"2022","unstructured":"Geng Y, Jin L, Tang G, Zhao Z, Gu Y, Yang D. LiqBioer: a manually curated database of cancer biomarkers in body fluid. Database (Oxford). 2022;2022:baac077.","journal-title":"Database (Oxford)"},{"issue":"1","key":"4249_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12943-020-01298-z","volume":"20","author":"S Wang","year":"2021","unstructured":"Wang S, Zhang K, Tan S, Xin J, Yuan Q, Xu H, et al. Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies. Mol Cancer. 2021;20(1):13.","journal-title":"Mol Cancer"},{"issue":"1","key":"4249_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s43094-023-00573-2","volume":"10","author":"DD Gadade","year":"2024","unstructured":"Gadade DD, Jha H, Kumar C, Khan F. Unlocking the power of precision medicine: exploring the role of biomarkers in cancer management. Future J Pharm Sci. 2024;10(1):5.","journal-title":"Future J Pharm Sci"},{"issue":"1","key":"4249_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12885-018-4022-5","volume":"18","author":"RL Evans","year":"2018","unstructured":"Evans RL, Pottala JV, Nagata S, Egland KA. Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality. BMC Cancer. 2018;18(1):119.","journal-title":"BMC Cancer"},{"key":"4249_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1161489","volume":"13","author":"Z Chen","year":"2023","unstructured":"Chen Z, Xing J, Zheng C, Zhu Q, He P, Zhou D, et al. Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection. Front Oncol. 2023;13:1161489.","journal-title":"Front Oncol"},{"issue":"1","key":"4249_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2014.03.021","volume":"85","author":"I Dogan","year":"2014","unstructured":"Dogan I, Kawabata S, Bergbower E, Gills JJ, Ekmekci A, Wilson W 3rd, et al. SOX2 expression is an early event in a murine model of EGFR mutant lung cancer and promotes proliferation of a subset of EGFR mutant lung adenocarcinoma cell lines. Lung Cancer. 2014;85(1):1\u20136.","journal-title":"Lung Cancer"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04249-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04249-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04249-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T03:10:10Z","timestamp":1787541010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04249-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["4249"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04249-0","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no potential conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Review Committee of the Shanxi Bethune Hospital (approval no. YXLL-2023\u2013261), and the experimental procedures were in agreement with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}